Loading the records…
Loading the records…
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH OLAO
National Institutes of Health is planning to buy "Renewal Service Agreement for VITEK Mass Spectrometer Prime". This is an early notice: it is not taking bids yet. The work is in Bethesda, MD, USA. The original due date (Apr 27, 2026) has passed; check the latest amendment for the current one. In the last 2 years, similar work went to 10 or more companies, usually for about $95K per award. An award could come any day: the usual time to award has passed.
Put together from the facts on this page; the details and sources are below.
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Every notice posted under solicitation NOI-26-000812 in this department, oldest first.
Standard steps for the notice type; not advice about this buyer.
and clauses in effect through Federal Acquisition Circular 2026-01, March 13, 2026. North American Classification System (NAICS) Code: 811210 Small business size standard: $34.0 in millions Set-aside Status: This requirement is not set aside for small businesses; this is a sole source requirement. Competition Status: This requirement is posted as limited source\sole source Description of Requirement: This is a Notice of Intent, not a request for proposal. The Office of Logistics and Office of Administration (OLAO), of the National Institutes of Health (NIH) intend to negotiate on an other than full and open competition bases with BioM�rieux Inc., 515 Colorow Drive, Salt Lake City, Utah 84108, USA, to procure a renewal maintenance/service agreement for a VITEK Mass Spectrometer Prime instrument. A renewal service agreement for a VITEK Mass Spectrometer with the serial numbers of SW-VT035937, SW-VT035938, MXL2082SZT, and ES00577 is to assure uninterrupted testing of microbiological agents from animal samples. Testing is performed by NIH veterinarians and assist in diagnosis and treatment of sick animals. The vendor is to provide renewal full service coverage and provide a preventive maintenance (PM) visit per year to ensure optimal performance, reliability, and compliance of the mass spectrometer system through routine preventive maintenance, calibration, and repair services. The VITEK MS is required to ensure compliance with federal animal welfare statutes, including the Animal Welfare Act, PHS Policy, and the Guide for the Care and Use of Laboratory Animals. Its implementation supports timely and accurate disease diagnosis, enhances veterinary care, mitigates zoonotic risk, and ensures adherence to AAALAC accreditation standards and federal quality assurance requirements. The current equipment VITEK MS uniquely interfaces with the existing VITEK II platform, allowing seamless integration of organism identification with antimicrobial susceptibility testing and confirmatory analysis. This interoperability is critical to minimizing identification errors, ensuring data integrity, and maintaining continuity within established laboratory workflows. No other vendor systems provide this level of compatibility with existing instrumentation. Failure to maintain the mass spectrometer under a qualified preventive maintenance program introduces significant risk to analytical accuracy, data integrity, regulatory compliance, and operational continuity. Improper servicing or use of non-authorized vendors may result in misidentification of clinically relevant organisms, loss of traceability, and inability to meet NIH, PHS, USDA, and AAALAC requirements. Additionally, due to the proprietary nature of the system�s software and databases, only authorized service providers can ensure continued system performance, validated results, and cybersecurity compliance. Specification of the requirement: Package #4707149 - Full Service Agreement VITEK MS Prime 1-Preventitive Maintenance visit during the performance year L-2-Maint Contract VITEK MS Prime Hotline 24/7 On-Site Repair 7/7 Local Business Hours Must be manufacturer-authorized, with demonstrated experience servicing proprietary mass spectrometry systems Maintain uptime, respond within 24�48 hours, and minimize disruption to lab operations Only authorized personnel may service equipment. Use of OEM-approved parts is required Coverage and response time equaling a direct contract and guaranteeing the equivalent manufacturer�s onsite support is required. If you are a third-party service provider, the response time and documentation of Manufacturer Certified technicians must be listed on a capabilities statement. Only one award will be made as a result of this solicitation. This will be awarded as a firm-fixed price type of contract. Period of Performance: Period of performance for full performance will be a base year of 6/1/2026 � 5/31/2027, and a one-year option period of 6/1/2027 � 5/31/2028. Service Location: NIH, 9000 Rockville Pike, Building 28A, Room 115, Bethesda, MD 20892. The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide this service may submit a capability statement to this to include evidence of being capable of providing priority service and a priority partnership with BioM�rieux Inc. Capability Statements submitted by third-party vendors must include a contract with BioM�rieux Inc. All Capability Statements must be received by Monday, April 27, 2026, 10:00am EST and must reference solicitation number NIH-26-000812 electronically to tonia.alexander@nih.gov. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
16 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same product/service code (PSC) J066.
Single-winner award sizes (16): middle half $43K to $239K, median $95K; range $14K to $696K.
| Winner | Awards | Value | Last |
|---|---|---|---|
| AGILENT TECHNOLOGIES INC · $A · $7.4B | 3 | $445K | Jul 24, 2025 |
| BECTON, DICKINSON AND COMPANY · $BDX · $22.5B | 2 | $567K | Nov 19, 2025 |
| Revvity Health Sciences, Inc. | 1 | $696K | Sep 24, 2025 |
| MOLECULAR DEVICES LLC | 1 | $236K | Nov 22, 2024 |
| CTF MEG NEURO INNOVATIONS INC | 1 | $185K | Sep 9, 2025 |
| ETS-LINDGREN INC · $ESE · $1.3B | 1 | $157K | Sep 10, 2025 |
| HAMILTON COMPANY | 1 | $124K | May 6, 2025 |
| ILLUMINA, INC. · $ILMN · $4.5B | 1 | $65K | Sep 16, 2025 |
| NANOCELLECT BIOMEDICAL INC | 1 | $58K | Mar 20, 2025 |
| ABBERIOR INSTRUMENTS AMERICA LLC | 1 | $46K | Dec 11, 2024 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
One award's total value against one year of revenue; many awards are paid over several years.
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.